Werewolf Therapeutics(HOWL) - 2023 Q4 - Annual Report
Werewolf Therapeutics(HOWL)2024-03-07 12:15Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Commission File Number: 001-40366 ______________________________________________________________________________________ WEREWOLF THERAPEUTICS, INC. ______________________________________________________________________________________ FORM 10-K ______________________________________________________________________________________ (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT ...